The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3.
Open accessAbstract
Previous investigations of p150,95 (CD11c), the third member of the CD18 membrane glycoprotein family that includes CR3 (Mac-1 or CD11b) and LFA-1 (CD11a), had demonstrated that solubilized p150,95 bound to iC3b-agarose in a manner similar to isolated CR3. The current study showed that membrane surface p150,95 also expressed iC3b-receptor activity and was probably the same as the neutrophil receptor for iC3b- or C3dg-coated erythrocytes (EC3bi or EC3dg) that had been previously designated CR4. Normal neutrophil and macrophage CR4-dependent EC3bi rosettes were inhibited by monoclonal anti-p150,95, and cells from a patient with CD18 deficiency did not form CR4-dependent EC3bi rosettes. With neutrophils that bore large amounts of CR1 and CR3 and little p150,95, EC3bi were found primarily via CR1 and CR3, and demonstration of p150,95-dependent rosettes required large amounts of fixed iC3b, low-ionic strength buffer, and antibody blockade of CR1 and CR3. By contrast, culture-derived macrophages expressed eight times more p150,95 than did monocytes and EC3bi were bound to both p150,95 and CR3 when EC3bi bore small amounts of fixed iC3b and assays were carried out in isotonic buffer. Comparison of the amounts of CR1, CR3, and CR4 in various tissues by immunoperoxidase staining revealed that CR4 was the most abundant C3 receptor molecule on tissue macrophages, and suggested that CR4 might be involved in clearance of C3-opsonized particles or immune complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins: A family of cell surface receptors
HYNES, R. (1987) · Cell · doi:10.1016/0092-8674(87)90233-9 · Cited by 4,249
Arg-Gly-Asp: A versatile cell recognition signal
Ruoslahti, E., & Pierschbacher, M. D. (1986) · Cell · doi:10.1016/0092-8674(86)90259-x · Cited by 1,397
LEUKOCYTE ADHESION DEFICIENCY: An Inherited Defect in the Mac-1, LFA-1, and p150,95 Glycoproteins
Anderson, D. C., & Springer, T. A. (1987) · Annual Review of Medicine · doi:10.1146/annurev.me.38.020187.001135 · Cited by 1,148
Sanchez-Madrid, F., Nagy, J. A., Robbins, E., Simon, P., & Springer, T. A. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.6.1785 · Cited by 873
Wright, S. D., Rao, P. E., Van Voorhis, W. C., Craigmyle, L. S., Iida, K., Talle, M. A., Westberg, E. F., Goldstein, G., & Silverstein, S. C. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.18.5699 · Cited by 663
Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.
Beller, D. I., Springer, T. A., & Schreiber, R. D. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.4.1000 · Cited by 606
Pohlman, T. H., Stanness, K. A., Beatty, P. G., Ochs, H. D., & Harlan, J. M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4548 · Cited by 588
KISHIMOTO, T. (1987) · Cell · doi:10.1016/0092-8674(87)90246-7 · Cited by 517
Primate erythrocyte-immune complex-clearing mechanism.
Cornacoff, J. B., Hebert, L. A., Smead, W. L., VanAman, M. E., Birmingham, D. J., & Waxman, F. J. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110764 · Cited by 489
Ross, G. D., Cain, J. A., & Lachmann, P. J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.5.3307 · Cited by 419
Self-citationWright, S. D., & Jong, M. T. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.6.1876 · Cited by 405
Arnaout, M. A., Todd, R. F., Dana, N., Melamed, J., Schlossman, S. F., & Colten, H. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110955 · Cited by 298
Miller, L. J., Schwarting, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.9.2891 · Cited by 288
Schwarting, R., Stein, H., & Wang, C. (1985) · Blood · doi:10.1182/blood.v65.4.974.974 · Cited by 276
Brodsky, F. M., & Parham, P. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.1.129 · Cited by 260
Bullock, W. E., & Wright, S. D. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.1.195 · Cited by 260
Law, S. K., Gagnon, J., Hildreth, J. E., Wells, C. E., Willis, A. C., & Wong, A. J. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04838.x · Cited by 213
Schreiber, A. D., & Frank, M. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106846 · Cited by 206
Wright, S. D., Reddy, P. A., Jong, M. T., & Erickson, B. W. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.1965 · Cited by 161
Newman, S. L., Musson, R. A., & Henson, P. M. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.5.2236 · Cited by 153
Rabellino, E. M., Nachman, R. L., Williams, N., Winchester, R. J., & Ross, G. D. (1979) · The Journal of Experimental Medicine · doi:10.1084/jem.149.6.1273 · Cited by 151
Self-citationLanier, L. L., Arnaout, M. A., Schwarting, R., Warner, N. L., & Ross, G. D. (1985) · European Journal of Immunology · doi:10.1002/eji.1830150714 · Cited by 149
Self-citationHogg, N., Takács, L., Palmer, D. G., Selvendran, Y., & Allen, C. A. (1986) · European Journal of Immunology · doi:10.1002/eji.1830160306 · Cited by 148
Self-citationThe CD11/CD18 Leukocyte Glycoprotein Deficiency
Todd, R. F., & Freyer, D. R. (1988) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30629-4 · Cited by 129
p150,95, the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family.
Springer, T. A., Miller, L. J., & Anderson, D. C. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.1.240 · Cited by 121
Micklem, K., & Sim, R. B. (1985) · Biochemical Journal · doi:10.1042/bj2310233 · Cited by 106
Keizer, G. D., Borst, J. G., Visser, W., Schwarting, R., de Vries, J. E., & Figdor, C. G. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.10.3130 · Cited by 105
Ross, G. D., Thompson, R., Walport, M. J., Springer, T., Watson, J. V., Ward, R., Lida, J., Newman, S. L., Harrison, R. A., & Lachmann, P. J. (1985) · Blood · doi:10.1182/blood.v66.4.882.882 · Cited by 94
Self-citationMalhotra, V., Hogg, N., & Sim, R. B. (1986) · European Journal of Immunology · doi:10.1002/eji.1830160915 · Cited by 93
Self-citationCellular distribution of complement receptor type 4 (CR4): expression on human platelets.
Vik, D. P., & Fearon, D. T. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.1.254 · Cited by 57
[7] Methods for the study of receptor-mediated phagocytosis
Wright, S. D. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(86)32009-3 · Cited by 31
Sl, N., Devery-Pocius, J. E., Gd, R., & Henson, P. M. (1984) · PubMed · Cited by 28
Ross, G. D. (1986) · Journal of Clinical Immunology · doi:10.1007/bf00918742 · Cited by 21
Self-citation
Cited by
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis
Savill, J., Dransfield, I., Hogg, N., & Haslett, C. (1990) · Nature · doi:10.1038/343170a0 · Cited by 846
Self-citationStructure and Function of Leukocyte Integrins
Larson, R. S., & Springer, T. A. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00565.x · Cited by 599
Metlay, J. P., Witmer-Pack, M. D., Agger, R., Crowley, M. T., Lawless, D., & Steinman, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1753 · Cited by 555
Complement: a unique innate immune sensor for danger signals
GASQUE, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.011 · Cited by 552
Metadata
- Authors
- Myones, B. L., Dalzell, J. G., Hogg, N., & Ross, G. D.
- Venue
- Journal of Clinical Investigation
- Published
- 1988-08-01
- Volume
- 82
- Issue
- 2
- Pages
- 640-651
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2023018499
- Cited by
- 265
- References
- 33
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.